Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Teva Pharma Industries Ltd ADR (TEVA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Teva ADR's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
13.23 -0.07    -0.53%
15/04 - Closed. Currency in USD ( Disclaimer )
After Hours
13.10
-0.13
-0.98%
0:59:08 - Real-time Data
  • Volume: 13,401,641
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 13.13 - 13.57
Type:  Equity
Market:  United States
Teva ADR 13.23 -0.07 -0.53%

TEVA Income Statement & Profits

 
Assess the Teva income statement, view the company's financial performance across their assets and liabilities. Select to view either quarterly or annual data.
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Revenue 4457 3850 3878 3661
Revenue 4457 3850 3878 3661
Other Revenue, Total - - - -
Cost of Revenue, Total 2041 1999 2082 2079
Gross Profit 2416 1851 1796 1582
Total Operating Expenses 3207 3089 3208 3163
Selling/General/Admin. Expenses, Total 902 844 910 842
Research & Development 227 253 240 234
Depreciation / Amortization -416 138 138 139
Interest Expense (Income) - Net Operating -328 -240 -226 -261
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 781 95 64 130
Operating Income 1250 761 670 498
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets 28 - - -
Other, Net 748 685 1584 755
Net Income Before Taxes 474 76 -914 -257
Provision for Income Taxes 41 -12 -16 -19
Net Income After Taxes 433 88 -898 -238
Minority Interest 620 582 656 751
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 429 80 -863 -205
Total Extraordinary Items - - - -
Net Income 429 80 -863 -205
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 429 80 -863 -205
Dilution Adjustment 3.78 0.55 -0.6 -4.3
Diluted Net Income 425.22 79.45 -862.4 -200.7
Diluted Weighted Average Shares 1137 1135 1120 1115
Diluted EPS Excluding Extraordinary Items 0.374 0.07 -0.771 -0.184
DPS - Common Stock Primary Issue - - - -
Diluted Normalized EPS 0.548 0.258 0.256 0.164
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TEVA Price Commentary

Write your thoughts about Teva Pharma Industries Ltd ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Rafi Shoev
Rafi Shoev Jan 22, 2024 23:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva 125years of developing new drugs bigest jeneic company andto be leader in biosimilar drugs.
Rafi Shoev
Rafi Shoev Jan 17, 2024 14:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva free cash flew aoutsyrnding
Rafi Shoev
Rafi Shoev Jan 16, 2024 15:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
24.02.24 Alboteck and teva .Humira biosimilar on the top of the day.from FDA.finally.
Rafi Shoev
Rafi Shoev Jan 16, 2024 15:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Freecash is very intresting???
Rafi Shoev
Rafi Shoev Jan 16, 2024 15:09
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Very atractiv ???
Rafi Shoev
Rafi Shoev Jan 15, 2024 10:08
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva revenew my hope will be more than 17.5bilions.
Rafi Shoev
Rafi Shoev Jan 12, 2024 19:41
Saved. See Saved Items.
This comment has already been saved in your Saved Items
If your stock is dawn its probably a time to by more.
Rafi Shoev
Rafi Shoev Jan 12, 2024 16:26
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Concidering to sturting by back .
Rafi Shoev
Rafi Shoev Jan 12, 2024 15:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The humira biosomilar wil be agaim changer
Rafi Shoev
Rafi Shoev Jan 12, 2024 14:08
Saved. See Saved Items.
This comment has already been saved in your Saved Items
jaint phrma is nomber one in tell aviv stock.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email